Abstract
Background. Bariatric surgery is a widely used treatment for morbid obesity. Prediction of postoperative weight loss currently relies on prediction models, which mostly overestimate patients’ weight loss. Data about the influence of Non-alcoholic fatty liver disease (NAFLD) on early postoperative weight loss are scarce. Methods. This prospective, single-center cohort study included 143 patients receiving laparoscopic gastric bypass surgery (One Anastomosis-Mini Gastric Bypass (OAGB-MGB) or Roux-en-Y Gastric Bypass (RYGB)). Liver biopsies were acquired at surgery. NAFLD activity score (NAS) assigned patients to “No NAFLD”, “NAFL” or “NASH”. Follow up data were collected at 3, 6 and 12 months. Results. In total, 49.7% of patients had NASH, while 41.3% had NAFL. Compared with the No NAFLD group, NAFL and NASH showed higher body-mass-index (BMI) at follow-up (6 months: 31.0 kg/m2 vs. 36.8 kg/m2 and 36.1 kg/m2, 12 months: 27.0 kg/m2 vs. 34.4 and 32.8 kg/m2) and lower percentage of total body weight loss (%TBWL): (6 months: 27.1% vs. 23.3% and 24.4%; 12 months: 38.5% vs. 30.1 and 32.6%). Linear regression of NAS points significantly predicts percentage of excessive weight loss (%EWL) after 6 months (Cologne-weight-loss-prediction-score). Conclusions. Histopathological presence of NAFLD might lead to inferior postoperative weight reduction after gastric bypass surgery. The mechanisms underlying this observation should be further studied.
Highlights
The obesity pandemic is responsible for a broad variety of obesity-related comorbidities
Based on histopathological NAFLD activity score (NAS) activity score in the liver biopsy, individuals were grouped into three groups: “No NALFD”, “nonalcoholic fatty liver (NAFL)” and “nonalcoholic steatohepatitis (NASH)”
While FIB-4 score did not differ significantly between the groups, it was lower in NALFD patients (Table 2)
Summary
The obesity pandemic is responsible for a broad variety of obesity-related comorbidities. Bariatric surgery is performed, since it is clinically and economically effective and safe, mainly due to improvement in laparoscopic techniques. It is possibly underutilized since less than 1% of obese adults receive this treatment [4,5]. Histopathological presence of NAFLD might lead to inferior postoperative weight reduction after gastric bypass surgery. The mechanisms underlying this observation should be further studied
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have